Physician profile
Malcolm Douglas
NPI 1730852021
$1,294.07
in general payments reported to CMS, 2019-2025
17 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $113 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.31 | 2025 | |
| Viiv Healthcare Company | $241.27 | 2025 | Apretude, Cabenuva, Dovato |
| Amgen INC. | $201.47 | 2025 | Krystexxa, Repatha, Otezla |
| Gilead Sciences, INC. | $128.12 | 2025 | |
| Exact Sciences Corporation | $59.46 | 2025 | The Cologuard Plus Collection Kit |
| Antares Pharma, INC. | $57.65 | 2025 | Xyosted |
| Intra-Sana Laboratories | $37.87 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Alkermes, INC. | $37.06 | 2024 | Aristada, Lybalvi |
| Astellas Pharma US INC | $30.32 | 2025 | Veozah |
| Pfizer INC. | $29.46 | 2025 | |
| Novo Nordisk INC | $28.17 | 2025 | Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.27 | 2024 | Caplyta |
| Averitas Pharma INC. | $26.12 | 2025 | Qutenza |
| Daiichi Sankyo INC. | $19.50 | 2025 | Injectafer |
| Axsome Therapeutics, INC. | $16.70 | 2024 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $16.62 | 2024 | Abilify Maintena, Abilify Asimtufii |
| Indivior INC. | $15.70 | 2024 | Perseris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.